Showing results (1631-1640 of 1,655) with videos related to
Sort By:
Pageof 166
Journal of Human Immunity|November 26, 2025
Novel genotypes, phenotypes, and triggers in humans with OTULIN haploinsufficiencyTristan J van der Linden, Rob J W Arts, Catherine M Biggs, et al.The Journal of Rheumatology|September 3, 2010
Power Doppler ultrasonography assessment of entheses in spondyloarthropathies: response to therapy of entheseal abnormalitiesEsperanza Naredo, Enrique Batlle-Gualda, M Luz García-Vivar, et al.International Journal of Cancer|September 5, 2018
Dietary folate intake and pancreatic cancer risk: Results from the European prospective investigation into cancer and nutritionJin Young Park, H Bas Bueno-de-Mesquita, Pietro Ferrari, et al.Nature Biotechnology|June 11, 2020
Benchmarking single-cell RNA-sequencing protocols for cell atlas projectsElisabetta Mereu, Atefeh Lafzi, Catia Moutinho, et al.Nature Cancer|April 26, 2022
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumorsBram Herpers, Berina Eppink, Mark I James, et al.International Journal of Cancer|December 2, 2016
Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohortM Matejcic, J de Batlle, C Ricci, et al.Journal of the National Cancer Institute|December 16, 2014
Dietary folate intake and breast cancer risk: European prospective investigation into cancer and nutritionJ de Batlle, P Ferrari, V Chajes, et al.ERJ Open Research|April 8, 2025
Longitudinal recovery trajectories and ventilatory modalities in COVID-19 acute respiratory distress syndrome survivorsJessica González, Iván D Benítez, Sally Santisteve, et al.International Journal of Cancer|September 8, 2016
Fiber intake modulates the association of alcohol intake with breast cancerIsabelle Romieu, Pietro Ferrari, Veronique Chajès, et al.British Journal of Cancer|June 1, 2013
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO studyC de la Piedra, A Alcaraz, J Bellmunt, et al.Pageof 166